Longeveron Inc. (LGVN)
NASDAQ · Healthcare
Longeveron Inc. EBITDA 2020–2025
Longeveron Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Longeveron Inc. ebitda for the quarter ending March 31, 2026 was -4.6 M, a 8.15% decrease year-over-year.
- Longeveron Inc. ebitda for the twelve months ending March 31, 2026 was -21.9 M, a 31.70% increase year-over-year.
- Longeveron Inc. annual ebitda for 2025 was -22.5 M, a 42.12% increase from 2024.
- Longeveron Inc. annual ebitda for 2024 was -15.8 M, a 22.17% decrease from 2023.
- Longeveron Inc. annual ebitda for 2023 was -20.3 M, a 17.22% increase from 2022.
- Longeveron Inc. annual ebitda for 2022 was -17.3 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Longeveron Inc. EBITDA — FAQ
Longeveron Inc. (LGVN) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LGVN's ebitda history?
The chart and table above show Longeveron Inc.'s ebitda by year and by quarter, including the growth rate.